MedDataX Logo

Cerebral Oxymetry in Traumatic Brain Injury

NCT ID: NCT01940861

Last Updated: 2014-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-11-30

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Vasopressor for current treatment protocols for acute traumatic brain injury can lead to vasoconstriction and thus cerebral hypoperfusion that can be detected with cerebral oxymetry as a drop in SCO2.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Traumatic brain injury

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with acute traumatic severe brain injury requiring neuro intensive care.
* The patient admitted must be at least 18 years of age and under 60 years.
* Intoxication is not an obstacle for inclusion as we believe this will not affect the recording in relation to our problem.

Exclusion Criteria

* Traumatic injury in the frontal lobes corresponding to the area where ScO2 monitored.
* Patients in pharmacological studies.
* Patients with severe heart / lung / blood vessel diseases.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Oslo University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oslo University Hospital

Oslo, Oslo County, Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ove Andreas Hagen, MD

Role: primary

[email protected]
+4790634748

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010/824

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

Co-TBI

Identifier Type: -

Identifier Source: org_study_id